Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic

The global health products supply chain is negatively influenced by the COVID-19 pandemic. Moreover, the risks in the pharmaceutical supply chain (PSC) have increased. Assessment and mitigation risks in PSC are essential issues to control and counter these risks. In this study, a 2-Tuple ARAS-BWM ap...

Descripción completa

Detalles Bibliográficos
Autores principales: BenAmor, W. Daoud, Labella, A., Frikha, H. Moalla, López, L. Martínez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: , IFAC (International Federation of Automatic Control) Hosting by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605720/
http://dx.doi.org/10.1016/j.ifacol.2022.10.035
Descripción
Sumario:The global health products supply chain is negatively influenced by the COVID-19 pandemic. Moreover, the risks in the pharmaceutical supply chain (PSC) have increased. Assessment and mitigation risks in PSC are essential issues to control and counter these risks. In this study, a 2-Tuple ARAS-BWM approach, which combines ARAS and BWM methods under linguistic 2-Tuple environment, is proposed to evaluate and address various risks to the best mitigation strategies in the pharmaceutical industry in Tunisia during COVID-19. Noted that the main risk identified in the PSC is related to supply and suppliers and its best mitigation strategy is reducing risk.

Ejemplares similares